Eastern Times Correspondent, Dhaka, 23 June : Bangladesh government has allowed the phase-3 trial of a Chinese Covid-19 vaccine candidate developed by the Institute of Medical Biology of the Chinese Academy of Medical Sciences (IMBCAMS).
“We have given ethical approval to the trial,” BMRC Chairman Prof Dr Syed Modasser Ali told The Our Correspondent this afternoon.
The BMRC chairman disclosed that the decision was taken after a request fro
The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) will conduct the trial, he said, adding that the exact timeframe will be revealed later.
The vaccine candidate is one of seven shots that were approved for use in China.
It was not immediately clear how many doses of the vaccine are currently produced and supplied for China’s inoculation campaign.
- SKM extends support to tribals of Chattisgarh protesting take over of village land and condemns firing >>>